GenBioPro Sues FDA To Keep Generic Mifepristone Available; Supreme Court Delays Its Decision

Courthouse
GenBioPro asks court to prevent FDA from taking enforcement action against its generic mifepristone • Source: Shutterstock

More from US FDA

More from Agency Leadership